Circulating donor-derived cell-free DNA: a true biomarker for cardiac allograft rejection?
Authors:
- Kevin P DalyKDKevin P Daly
- Kevin P.KPKevin P.
Open Access
- 1 March 2015
- journal article
- Vol. 3 (4)
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- The Registry of the International Society for Heart and Lung Transplantation: Seventeenth Official Pediatric Heart Transplantation Report—2014; Focus Theme: RetransplantationThe Journal of Heart and Lung Transplantation, 2014
- 2013 ACC/AHA Guideline on the Assessment of Cardiovascular RiskCirculation, 2014
- Circulating Cell-Free DNA Enables Noninvasive Diagnosis of Heart Transplant RejectionScience Translational Medicine, 2014
- Highly Sensitive Noninvasive Cardiac Transplant Rejection Monitoring Using Targeted Quantification of Donor-Specific Cell-Free Deoxyribonucleic AcidJACC, 2014
- The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantationThe Journal of Heart and Lung Transplantation, 2013
- A web-based pilot study of inter-pathologist reproducibility using the ISHLT 2004 working formulation for biopsy diagnosis of cardiac allograft rejection: The European experienceThe Journal of Heart and Lung Transplantation, 2011
- Rejection with hemodynamic compromise in the current era of pediatric heart transplantation: A multi-institutional studyThe Journal of Heart and Lung Transplantation, 2011
- Alemtuzumab (Campath 1H) as Successful Salvage Therapy for Recurrent Steroid-resistant Heart Transplant RejectionThe Journal of Heart and Lung Transplantation, 2007
- Revision of the 1990 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart RejectionThe Journal of Heart and Lung Transplantation, 2005
- Risk factors for recurrent rejection in pediatric heart transplantation: a multicenter experienceThe Journal of Heart and Lung Transplantation, 2004